ARTICLE | Clinical News
Axis Biochemicals regulatory update
October 19, 1998 7:00 AM UTC
The FDA granted marketing approval for AXI's Homocysteine IMx automated immunoassay for the amino acid homocysteine to predict cardiovascular disease. The product will be distributed in the U.S. by pa...